| Screening | Randomisation (Pre-treatment) | Month 2 | Month 6 | Month 9 | Month 12 (Post-treatment) | Month 15 (Post-trial) |
---|---|---|---|---|---|---|---|
Inclusion and exclusion criteria checklist | EM | Â | Â | Â | Â | Â | Â |
Case-note diagnostic checklist | EM | Â | Â | Â | Â | Â | Â |
Diagnostic and eligibility checklist | EM and CO | Â | Â | Â | Â | CO | Â |
Mini-International Neuropsychiatric Interview | EM and CO | Â | Â | Â | Â | CO | Â |
Positive and Negative Syndrome Scale | EM and CO | CO | CO | CO | CO | CO | CO |
Wechsler Adult Intelligence Scale III; 4 subtest short form | EM and CO | Â | Â | Â | Â | CO | CO |
Wechsler Test of Adult Reading | EM and CO | Â | Â | Â | Â | Â | Â |
Verbal fluency | EM and CO | Â | Â | Â | Â | CO | CO |
Auditory-Verbal Learning Task | EM and CO | Â | Â | Â | Â | CO | CO |
Medication treatment history | EM and CO | CO | CO | CO | CO | CO | CO |
Pregnancy urine dipstick test | EM | WCM | WCM | WCM | WCM | WCM | Â |
Drug urine screening test | EM | Â | Â | WCM | Â | Â | Â |
Drug use questionnaire | EM | WCM | WCM | WCM | WCM | WCM | SCo |
Blood laboratory screening for kidney and liver function | EM | Â | Â | Â | Â | WCM | Â |
Blood pressure and heart rate | EM | Â | Â | Â | Â | WCM | SCo |
MRI screening questionnaire | EM | Â | Â | Â | Â | Â | Â |
Duration of untreated psychosis | RP | Â | Â | Â | Â | Â | Â |
Body weight and body mass index | Â | CO | Â | Â | Â | CO | CO |
Global Assessment of Functioning | Â | CO | CO | CO | CO | CO | CO |
Social Functioning Scale | Â | CO | Â | CO | Â | CO | CO |
MRI scanning | Â | BO | Â | Â | Â | BO | Â |
Blood cytokine screen test | Â | BO | Â | BO | Â | BO | BO |
Saliva Oragene kit for DNA donation | Â | RP | Â | Â | Â | Â | Â |
Withdrawal criteria checklist | Â | WCM | WCM | WCM | WCM | WCM | Â |
Calgary Depression Scale for Schizophrenia | Â | SCo | SCo | SCo | SCo | SCo | SCo |
Simpson and Angus Scale | Â | SCo | Â | SCo | Â | SCo | SCo |
Barnes Akathisia Scale | Â | SCo | Â | SCo | Â | SCo | SCo |
Abnormal Involuntary Movements Scale | Â | SCo | Â | SCo | Â | SCo | SCo |
Antipsychotic Non-Neurological Side-Effects Rating Scale | Â | SCo | SCo | SCo | SCo | SCo | SCo |
7-point compliance scale | Â | Â | AT | AT | AT | AT | Â |